Market Overview:
The global radioactive stent used for cancer treatments market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into 18mm stent, 20mm stent, 14mm stent, and other stents. The 18mm Stent segment is expected to dominate the global radioactive stent used for cancer treatments market in terms of revenue share during the forecast period from 2018 to 2030. On the basis of application, esophageal cancer accounted for majority share in 2017 and it is projected to maintain its dominance throughout the forecast period from 2018 to 2030 owing to increasing incidence rate globally.
Product Definition:
A radioactive stent is a medical device that is inserted into an artery to help keep it open. It is used for the treatment of cancer, specifically to deliver radiation therapy directly to the tumor.
18mm Stent:
18mm stent used for radioactive treatments is a new type of stent that has been designed especially for the treatment of cancer. It works by taking advantage of the natural tendency of cells in the body to divide and grow. The special property exhibited by this product is that it can capture, hold and remove abnormal cells without affecting healthy tissues.
20mm Stent:
20mm Stent is a kind of radio-labeled stent used for the treatment of cancer. It works by delivering a high dose of radiation to the area affected by cancer. The 20 mm stent was designed as an alternative to 8 mm and 14 mm conventional radioisotope-containing stents that are currently used in oncology treatments.
Application Insights:
The others application segment includes lung, breast and other cancers. Radioactive sources are used for treating various types of cancer including esophageal, biliary and others. The use of radioactive sources in the treatment of esophageal cancer accounted for the largest market share in 2017 owing to availability of advanced therapies such as EBRT which is highly effective than conventional treatments such as surgery or chemotherapy.
EBRT uses a technique known as intensity-modulated radiation therapy (IMRT) which enables precise targeting of tumor cells while reducing exposure to healthy organs at risk from surrounding tumors. This technology has resulted in improved outcomes with less damage to surrounding tissues thus making it an ideal choice among healthcare professionals for the treatment Esophageal & Biliary Cancers.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of major players and increased adoption of advanced technologies. The region is expected to maintain its dominance over the forecast period due to increasing cases of esophageal cancer, liver cancers, and others. In addition, rising government initiatives for research & development activities are also anticipated to drive growth in this region. For instance, Global Stem Cell Foundation (GSCF) has initiated a project named “GSCF Research Program†which focuses on research related stem cells transplantation therapies for various diseases such as diabetes (islet cell transplant), Parkinson’s disease (neurotransplant), and others.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the radioactive stent used for cancer treatments market. According to the World Health Organization (WHO), in 2012, there were 14 million new cases of cancer and 8.2 million deaths from the disease worldwide. This number is expected to increase to 21 million new cases and 13 million deaths by 2030. This will create a large demand for radioactive stents used in various types of cancers, thereby driving the market growth.
- Technological advancements: The technological advancements in radiation therapy are another key factor driving market growth. For instance, recent advances include intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), which help improve accuracy and precision while delivering radiation treatment doses to tumors or lesions site-specifically with reduced side effects as compared to traditional radiotherapy methods such as 3D conformal radiotherapy or even brachytherapy techniques using implanted radioactive sources.. These technological advancements are likely to fuel demand for radioactive stents over the forecast period..
Scope Of The Report
Report Attributes
Report Details
Report Title
Radioactive Stent Used for Cancer Treatments Market Research Report
By Type
18mm Stent, 20mm Stent, 14mm Stent, Other Stents
By Application
Esophageal Cancer, Biliary Cancer, Others
By Companies
Micro-Tech, Changzhou Zhiye, Changzhou Garson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Radioactive Stent Used for Cancer Treatments Market Report Segments:
The global Radioactive Stent Used for Cancer Treatments market is segmented on the basis of:
Types
18mm Stent, 20mm Stent, 14mm Stent, Other Stents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Esophageal Cancer, Biliary Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Micro-Tech
- Changzhou Zhiye
- Changzhou Garson
Highlights of The Radioactive Stent Used for Cancer Treatments Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 18mm Stent
- 20mm Stent
- 14mm Stent
- Other Stents
- By Application:
- Esophageal Cancer
- Biliary Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Radioactive Stent Used for Cancer Treatments Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Radioactive stents are used in cancer treatments to help destroy cancer cells.
Some of the major players in the radioactive stent used for cancer treatments market are Micro-Tech, Changzhou Zhiye, Changzhou Garson.
The radioactive stent used for cancer treatments market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Radioactive Stent Used for Cancer Treatments Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Radioactive Stent Used for Cancer Treatments Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Radioactive Stent Used for Cancer Treatments Market - Supply Chain
4.5. Global Radioactive Stent Used for Cancer Treatments Market Forecast
4.5.1. Radioactive Stent Used for Cancer Treatments Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Radioactive Stent Used for Cancer Treatments Market Size (000 Units) and Y-o-Y Growth
4.5.3. Radioactive Stent Used for Cancer Treatments Market Absolute $ Opportunity
5. Global Radioactive Stent Used for Cancer Treatments Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Type
5.3.1. 18mm Stent
5.3.2. 20mm Stent
5.3.3. 14mm Stent
5.3.4. Other Stents
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Radioactive Stent Used for Cancer Treatments Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Application
6.3.1. Esophageal Cancer
6.3.2. Biliary Cancer
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Radioactive Stent Used for Cancer Treatments Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Radioactive Stent Used for Cancer Treatments Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Radioactive Stent Used for Cancer Treatments Demand Share Forecast, 2019-2026
9. North America Radioactive Stent Used for Cancer Treatments Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Application
9.4.1. Esophageal Cancer
9.4.2. Biliary Cancer
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Type
9.7.1. 18mm Stent
9.7.2. 20mm Stent
9.7.3. 14mm Stent
9.7.4. Other Stents
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Radioactive Stent Used for Cancer Treatments Demand Share Forecast, 2019-2026
10. Latin America Radioactive Stent Used for Cancer Treatments Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Application
10.4.1. Esophageal Cancer
10.4.2. Biliary Cancer
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Type
10.7.1. 18mm Stent
10.7.2. 20mm Stent
10.7.3. 14mm Stent
10.7.4. Other Stents
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Radioactive Stent Used for Cancer Treatments Demand Share Forecast, 2019-2026
11. Europe Radioactive Stent Used for Cancer Treatments Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Application
11.4.1. Esophageal Cancer
11.4.2. Biliary Cancer
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Radioactive Stent Used for Cancer Treatment Market Size and Volume Forecast by Type
11.7.1. 18mm Stent
11.7.2. 20mm Stent
11.7.3. 14mm Stent
11.7.4. Other Stents
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Radioactive Stent Used for Cancer Treatments Demand Share, 2019-2026
12. Asia Pacific Radioactive Stent Used for Cancer Treatments Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Application
12.4.1. Esophageal Cancer
12.4.2. Biliary Cancer
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Type
12.7.1. 18mm Stent
12.7.2. 20mm Stent
12.7.3. 14mm Stent
12.7.4. Other Stents
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Radioactive Stent Used for Cancer Treatments Demand Share, 2019-2026
13. Middle East & Africa Radioactive Stent Used for Cancer Treatments Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Application
13.4.1. Esophageal Cancer
13.4.2. Biliary Cancer
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Radioactive Stent Used for Cancer Treatments Market Size and Volume Forecast by Type
13.7.1. 18mm Stent
13.7.2. 20mm Stent
13.7.3. 14mm Stent
13.7.4. Other Stents
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Radioactive Stent Used for Cancer Treatments Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Radioactive Stent Used for Cancer Treatments Market: Market Share Analysis
14.2. Radioactive Stent Used for Cancer Treatments Distributors and Customers
14.3. Radioactive Stent Used for Cancer Treatments Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Micro-Tech
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Changzhou Zhiye
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Changzhou Garson
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
